Apr 25, 2022 ... The small device is designed to enable more individualized application of light dosing and photodynamic therapy. Justin Baetge/Texas A&M ...
Apr 4, 2022 ... A drug widely used in HIV therapy has shown to stop disease progression in 25 percent of patients with fourth-line metastatic colorectal ...
Apr 27, 2022 ... The researchers are now setting up just such a clinical trial of BHB—which is widely available as a dieting supplement—in colorectal cancer ...
Mar 12, 2023 ... There are several types of colorectal cancer, based on where it starts. Adenocarcinoma. This is the most common kind, making up 96% of cases. It ...
Feb 4, 2024 ... ... treatment of colorectal cancer. ... drug sensitivity between two subtypes and found significant differences in drug sensitivity between them.
Feb 1, 2024 ... "It's somewhat similar to the evolution of breast cancer care," Fleming says. "Patients used to have very extensive mastectomies and resections, ...
Jul 22, 2022 ... He was referred to a gastroenterologist for a colonoscopy, which unfortunately found an obstructing mass in the rectum of the sigmoid colon and ...
Jan 13, 2023 ... Colorectal cancer, called colon cancer for short, is a malignant condition that occurs when there's abnormal cell growth in the colon or rectum.
Jun 5, 2022 ... The data reported by Cercek and colleagues are potentially practice-changing, as patients with stage II or stage III rectal cancer usually ...
Oct 28, 2022 ... The results of a phase I clinical trial show that a new drug candidate could safely target pancreatic, lung, colon, and other cancers in ...
Feb 14, 2014 ... 21, 2019 — Chemotherapy and radiation therapy are commonly used to treat cancer, but are not always effective and can have toxic side effects.
May 2, 2022 ... "There is no targeted treatment for PIK3CA mutant colorectal cancer, and our research may lead to new therapy options." The scientists ...
Feb 11, 2020 ... "Our data suggest that the initial primary surgery treatment options for rectal cancer are almost always available in patients with local ...
Jun 8, 2022 ... Dostarlimab has been developed by the pharmaceutical company GlaxoSmithKline. The drug was given to the patients every three to six months at a ...
Jun 5, 2022 ... A scientist comments on the evolving treatment of rectal cancer in light of findings from a study that found the immunotherapy drug ...
Jun 6, 2022 ... In an unprecedented clinical trial, a dozen rectal cancer patients saw their tumors disappear after they received an experimental drug ...
Jun 21, 2022 ... ... bowel. The various treatment options for OCRC opted at our center were right hemicolectomy, extended right hemicolectomy, left hemicolectomy ...